Anna Czlonkowska

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 303 publications

Prevalence of Wilson's disease in Poland.

Prevalence of Wilson's disease in Poland.

Journal: Polish archives of internal medicine

Published: August 25, 2026

Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis.

Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis.

Journal: Stroke

Published: August 20, 2026

Non-contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage: An Analysis from ANNEXa-I Trial.

Non-contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage: An Analysis from ANNEXa-I Trial.

Journal: Annals of neurology

Published: April 28, 2026

Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial.

Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial.

Journal: European stroke journal

Published: February 05, 2026

Wilson's disease: does a neuropsychiatric phenotype without liver involvement truly exist?

Wilson's disease: does a neuropsychiatric phenotype without liver involvement truly exist?

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: January 29, 2026

Contemporary achievement of guideline recommendations for blood pressure management after stroke in the CONVINCE trial.

Contemporary achievement of guideline recommendations for blood pressure management after stroke in the CONVINCE trial.

Journal: European stroke journal

Published: January 20, 2026

Effect of colchicine for secondary prevention according to stroke subtype: A secondary analysis of the CONVINCE randomized trial.

Effect of colchicine for secondary prevention according to stroke subtype: A secondary analysis of the CONVINCE randomized trial.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: December 02, 2025

Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease: Monitoring chelation treatment in Wilson disease.

Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease: Monitoring chelation treatment in Wilson disease.

Journal: JHEP reports : innovation in hepatology

Published: September 22, 2025

Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease.

Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease.

Journal: JHEP reports : innovation in hepatology

Published: September 22, 2025

Clinical Determinants and Prognostic Impact of Delayed Diagnosis in Wilson's Disease.

Clinical Determinants and Prognostic Impact of Delayed Diagnosis in Wilson's Disease.

Journal: Diagnostics (Basel, Switzerland)

Published: July 19, 2025

Liver-related autoantibodies in Wilson disease: increased prevalence and unclear clinical significance.

Liver-related autoantibodies in Wilson disease: increased prevalence and unclear clinical significance.

Journal: Advances in medical sciences

Published: July 17, 2025

Discovery of new MicroRNAs and their mRNA targets in patients with acute ischemic stroke.

Discovery of new MicroRNAs and their mRNA targets in patients with acute ischemic stroke.

Journal: BMC medical genomics

Published: July 09, 2025

Showing 1-12 of 303

Last Updated: 09/26/2026